Pancreatic Cancer Research

ResearcherUniversità Cattolica del Sacro CuoreActive in the last 2 years

Teresa Mezza

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5407-9576; OpenAlex author ID A5071134404. Sources: ClinicalTrials.gov.

Their work

Papers
2
Trials
3 (principal investigator on 3)
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 3 trials

Papers 2

  1. Surgical treatment of synchronous liver-only oligometastatic pancreatic adenocarcinoma: a systematic review and meta-analysis of long-term outcomes. Co-author DOI 10.1097/js9.0000000000002338↗
  2. Pancreatic Cancer Resistance to Treatment: The Role of Microbiota. Co-author DOI 10.3390/biomedicines11010157↗

Trials 3

  1. Clinical, Oncological and Metabolic Effects of Pancreatic Mass Loss After Partial, Near-total and Total Pancreatectomy in Patients With Preoperative Diabetes M… Principal investigator NCT07607912↗
  2. Clinical, Oncologic, and Metabolic Effects of Pancreatic Mass Loss After Pancreatectomy in Non-Diabetic Patients Principal investigator NCT07608055↗
  3. Exocrine-Endocrine Pancreatic Crosstalk: Precision Pathways to Reframe Diabetes Pathophysiology Principal investigator NCT07670871↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Claudio Fiorillo · 1 shared paper, 2025 · strength 0.22
  2. Giuseppe Quero · 1 shared paper, 2025 · strength 0.22
  3. Sergio Alfieri · 1 shared paper, 2025 · strength 0.22
  4. Marcello Candelli · 1 shared paper, 2023 · strength 0.18
  5. Enrico Celestino Nista · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.